Physician profile
Wayne Murphy
NPI 1407888357
$606.66
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $50.72 · 2021: $121 · 2022: $187 · 2023: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $108.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $162.99 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $85.95 | 2019-2023 | Farxiga |
| Novo Nordisk INC | $57.65 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $51.76 | 2019-2021 | |
| Insulet Corporation | $47.89 | 2022 | |
| Glaxosmithkline, LLC. | $42.59 | 2023 | Shingrix |
| Sanofi Pasteur INC. | $37.54 | 2022 | |
| Abbott Laboratories | $32.27 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $19.75 | 2022 | |
| Exact Sciences Corporation | $16.07 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $14.28 | 2019 | |
| Mylan Specialty L.P. | $13.19 | 2019 | |
| Antares Pharma, INC. | $12.73 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.